NasdaqGS - Delayed Quote USD
Innoviva, Inc. (INVA)
18.01
-0.25
(-1.37%)
At close: May 14 at 4:00:01 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 58,027 | 5 |
| Sales | 1,618,295 | 1 |
| Net Shares Purchased (Sold) | -1,560,268 | 6 |
| Total Insider Shares Held | 617.08k | -- |
| % Net Shares Purchased (Sold) | -71.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| RAIFELD PAVEL Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 17.39 per share. | Direct | 649,986 | Mar 14, 2025 |
| DENNER ALEXANDER J Beneficial Owner of more than 10% of a Class of Security | Sale at price 17.52 - 17.63 per share. | Indirect | 28,395,442 | Mar 6, 2025 |
| ZHEN MARIANNE Y Officer | Stock Award(Grant) at price 18.08 per share. | Direct | 161,599 | Feb 24, 2025 |
| BASSO STEPHEN Chief Financial Officer | Stock Award(Grant) at price 18.08 per share. | Direct | 191,088 | Feb 24, 2025 |
| ZHEN MARIANNE Y Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 15, 2024 |
| BASSO STEPHEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 15, 2024 |
| HAIMOVITZ JULES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 17, 2024 |
| ODYSSEAS KOSTAS D. M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 17, 2024 |
| SRIVASTAVA SAPNA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 17, 2024 |
| SCHLESINGER SARAH J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 17, 2024 |
| SMALL DEREK A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 17, 2024 |
| DIPAOLO MARK A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 17, 2024 |
| ZHEN MARIANNE Y Officer | Stock Award(Grant) at price 14.88 per share. | Direct | 159,990 | Mar 5, 2024 |
| BASSO STEPHEN Chief Financial Officer | Stock Award(Grant) at price 14.88 per share. | Direct | 179,988 | Mar 5, 2024 |
| RONSHEIM MATTHEW Officer | Stock Award(Grant) at price 14.88 per share. | Direct | 189,988 | Mar 5, 2024 |
| ZHEN MARIANNE Y Officer | Sale at price 13.97 - 14.01 per share. | Direct | 153,810 | Nov 15, 2023 |
| ZHEN MARIANNE Y Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 15, 2023 |
| DENNER ALEXANDER J Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.13 per share. | Indirect | 814,196 | Jun 15, 2023 |
| DENNER ALEXANDER J Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.04 - 13.05 per share. | Indirect | 195,681 | Jun 6, 2023 |
| DENNER ALEXANDER J Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.01 - 13.12 per share. | Indirect | 2,608,707 | May 30, 2023 |
| HAIMOVITZ JULES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
| ODYSSEAS KOSTAS D. M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
| SRIVASTAVA SAPNA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
| SCHLESINGER SARAH J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
| DIPAOLO MARK A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
| BIRX DEBORAH L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
| DENNER ALEXANDER J Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.05 - 13.48 per share. | Indirect | 1,269,375 | May 19, 2023 |
Related Tickers
TBPH Theravance Biopharma, Inc.
8.41
-5.61%
ENTA Enanta Pharmaceuticals, Inc.
5.18
-0.96%
XNCR Xencor, Inc.
8.14
+0.37%
HRMY Harmony Biosciences Holdings, Inc.
33.39
-2.85%
CDTX Cidara Therapeutics, Inc.
19.31
-0.28%
CGEM Cullinan Therapeutics, Inc.
7.13
-6.43%
SLRX Salarius Pharmaceuticals, Inc.
0.8699
+11.23%
PBYI Puma Biotechnology, Inc.
2.9000
-3.65%
FOLD Amicus Therapeutics, Inc.
5.88
-2.33%
ARMP Armata Pharmaceuticals, Inc.
1.3800
-2.82%